EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impressive Skin and Systemic Response Despite Patient Underestimation and Delayed Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm

Emanuele Pacini iD, Beatrice Esposito Vangone iD, Adele Santoni iD, Margherita Malchiodi iD, Corrado Zuanelli Brambilla iD, Anna Sicuranza iD, Giulia Beffa iD, Monica Bocchia iD

Case Reports in Hematology · 2026-01 · 2026 (1)

DOI: 10.1155/crh/4591883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Hematology, online erschienen am 18.07.2026. Verfasst von Emanuele Pacini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Unit, University Hospital of Siena, Siena, Italy, unisi.it. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy derived from precursors of plasmacytoid dendritic cells (pDCs), most frequently presenting with cutaneous involvement and often progressing to bone marrow (BM), lymph node, and central nervous system (CNS) infiltration. Owing to its heterogeneous and often indolent initial presentation, diagnosis is frequently delayed, potentially worsening prognosis. We report the case of a 55‐year‐old man with long‐standing underrecognized cutaneous and nodal lesions that eventually evolved into disseminated BPDCN. The patient was successfully treated with intensive chemotherapy (CHT) using a hyper‐CVAD regimen combined with intrathecal therapy (IT), achieving complete remission (CR). Consolidation with allogeneic hematopoietic stem cell transplantation (allo‐HSCT) from a matched sibling donor resulted in sustained minimal residual disease (MRD)–negative CR. At 23 months post transplant, the patient remains disease‐free with full donor chimerism and no evidence of graft‐versus‐host disease (GvHD). This case highlights the diagnostic challenges of BPDCN, the importance of early recognition of atypical cutaneous lesions, and supports the role of intensive CHT followed by allo‐HSCT as an effective therapeutic strategy in eligible patients.

Autor:innen und Institutionen

  • Hematology Unit, University Hospital of Siena, Siena, Italy, unisi.it.
  • Hematology Unit, San Donato Hospital, Arezzo, Italy, sandonato-gsd.it.
  • Stem Cell Transplant and Cellular Therapy Unit, University Hospital of Siena, Siena, Italy, unisi.it.

ORCID-Profile: Emanuele Pacini, Beatrice Esposito Vangone, Adele Santoni, Margherita Malchiodi, Corrado Zuanelli Brambilla, Anna Sicuranza, Giulia Beffa, Monica Bocchia

Zitieren

APA

Pacini, E., Esposito Vangone, B., Santoni, A., Malchiodi, M., Zuanelli Brambilla, C., Sicuranza, A., Beffa, G., & Bocchia, M. (2026). Impressive Skin and Systemic Response Despite Patient Underestimation and Delayed Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm. Case Reports in Hematology, 2026(1). https://doi.org/10.1155/crh/4591883

Vancouver

Pacini E, Esposito Vangone B, Santoni A, Malchiodi M, Zuanelli Brambilla C, Sicuranza A, et al. Impressive Skin and Systemic Response Despite Patient Underestimation and Delayed Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm. Case Reports in Hematology. 2026;2026(1). doi:10.1155/crh/4591883

BibTeX
@article{Pacini2026,
  author = {Pacini, Emanuele and Esposito Vangone, Beatrice and Santoni, Adele and Malchiodi, Margherita and Zuanelli Brambilla, Corrado and Sicuranza, Anna and Beffa, Giulia and Bocchia, Monica},
  title = {Impressive Skin and Systemic Response Despite Patient Underestimation and Delayed Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm},
  journal = {Case Reports in Hematology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crh/4591883}
}
Kostenlos starten →